Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics & Research Market Cap: $521.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.95% Avg Daily Range (30 D): $0.30 | 2.36% Avg Daily Range (90 D): $0.28 | 2.58% Institutional Daily Volume Avg Daily Volume: .07M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 272 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $1.14M Avg Inst. Trade (90 D): $1.28M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.68M Avg Closing Volume: 156.69K     News Jul 8, 2025 @ 2:25 PM Amid NCI Budget Fears, Emerging Oncology Stocks Ga... Source: Prnewswire Feb 27, 2025 @ 3:04 PM Oncology Breakthroughs: How Cancer Research Is Adv... Source: Prnewswire Jun 3, 2024 @ 8:01 PM Celcuity To Participate in Jefferies Global Health... Source: Celcuity Inc. May 30, 2024 @ 11:36 AM Celcuity Announces Pricing of Underwritten Common ... Source: Celcuity Inc. May 30, 2024 @ 11:00 AM Celcuity Inc. Announces Plan to Initiate a Phase 3... Source: Celcuity Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.05 $-.86 $-.87 Diluted EPS $-3.05 $-.86 $-.87 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -127.16M $ -37M $ -36.65M Operating Income / Loss $ -126.91M $ -36.13M $ -36.43M Cost of Revenue $ $ $ Net Cash Flow $ -14.74M $ -6.04M $ 9.91M PE Ratio